paroxetine for vasomotor
Selected indexed studies
- Management of Menopausal Symptoms: A Review. (JAMA, 2023) [PMID:36749328]
- A review of paroxetine for the treatment of vasomotor symptoms. (J Pharm Pract, 2015) [PMID:25107421]
- Critical appraisal of paroxetine for the treatment of vasomotor symptoms. (Int J Womens Health, 2015) [PMID:26124682]
_Worker-drafted node — pending editorial review._
Connections
paroxetine for vasomotor is a side effect of
Sources
- Hormone Therapy and Other Treatments for Symptoms of Menopause. (2016) pubmed
- Management of Menopausal Symptoms: A Review. (2023) pubmed
- Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause. (2024) pubmed
- A review of paroxetine for the treatment of vasomotor symptoms. (2015) pubmed
- Critical appraisal of paroxetine for the treatment of vasomotor symptoms. (2015) pubmed
- A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms. (2022) pubmed
- Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis. (2016) pubmed
- Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis. (2023) pubmed
- Menopause. (2008) pubmed
- New pharmacological therapies for vasomotor symptom management: focus on bazedoxifene/conjugated estrogens and paroxetine mesylate. (2014) pubmed